<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982151</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Effects of l-Arginine Plus Vitamin C Supplementation on l-Arginine Metabolism in Adults with Long COVID: Secondary Analysis of a Randomized Clinical Trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5078</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065078</ELocationID><Abstract><AbstractText>Altered l-arginine metabolism has been described in patients with COVID-19 and has been associated with immune and vascular dysfunction. In the present investigation, we determined the serum concentrations of l-arginine, citrulline, ornithine, monomethyl-l-arginine (MMA), and symmetric and asymmetric dimethylarginine (SDMA, ADMA) in adults with long COVID at baseline and after 28-days of l-arginine plus vitamin C or placebo supplementation enrolled in a randomized clinical trial, compared with a group of adults without previous history of SARS-CoV-2-infection. l-arginine-derived markers of nitric oxide (NO) bioavailability (i.e., l-arginine/ADMA, l-arginine/citrulline+ornithine, and l-arginine/ornithine) were also assayed. Partial least squares discriminant analysis (PLS-DA) models were built to characterize systemic l-arginine metabolism and assess the effects of the supplementation. PLS-DA allowed discrimination of participants with long COVID from healthy controls with 80.2 &#xb1; 3.0% accuracy. Lower markers of NO bioavailability were found in participants with long COVID. After 28 days of l-arginine plus vitamin C supplementation, serum l-arginine concentrations and l-arginine/ADMA increased significantly compared with placebo. This supplement may therefore be proposed as a remedy to increase NO bioavailability in people with long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Calvani</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5472-2365</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gervasoni</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3600-392X</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picca</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7032-3487</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, LUM University, 70010 Casamassima, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciciarello</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galluzzo</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-4620-5979</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coelho-J&#xfa;nior</LastName><ForeName>H&#xe9;lio Jos&#xe9;</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0001-7482-9514</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Mario</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Immunology Core Facility, Gemelli Science Technological Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gremese</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Core Facility, Gemelli Science Technological Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomuscio</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Metabolomics Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paglionico</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santucci</LastName><ForeName>Lavinia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Metabolomics Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolusso</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Immunology Core Facility, Gemelli Science Technological Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-8266-1117</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzetti</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9567-6983</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe0; Cattolica del Sacro Cuore, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosato</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5750-9746</Identifier><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Gemelli against COVID-19 Post-Acute Care Team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>29VT07BGDA</RegistryNumber><NameOfSubstance UI="D002956">Citrulline</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>E524N2IXA3</RegistryNumber><NameOfSubstance UI="D009952">Ornithine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002956" MajorTopicYN="N">Citrulline</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009952" MajorTopicYN="N">Ornithine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADMA</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">flow-mediated dilation</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">nitric oxide</Keyword><Keyword MajorTopicYN="N">nutraceuticals</Keyword><Keyword MajorTopicYN="N">oral supplement</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. l-arginine plus vitamin C supplement and placebo were donated by Farmaceutici Damor, Naples, Italy. The supplier had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982151</ArticleId><ArticleId IdType="pmc">PMC10049539</ArticleId><ArticleId IdType="doi">10.3390/ijms24065078</ArticleId><ArticleId IdType="pii">ijms24065078</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gambardella J., Khondkar W., Morelli M.B., Wang X., Santulli G., Trimarco V. Arginine and endothelial function. Biomedicines. 2020;8:277. doi: 10.3390/biomedicines8080277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8080277</ArticleId><ArticleId IdType="pmc">PMC7460461</ArticleId><ArticleId IdType="pubmed">32781796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005;5:641&#x2013;654. doi: 10.1038/nri1668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1668</ArticleId><ArticleId IdType="pubmed">16056256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu G., Morris S.M. Arginine metabolism: Nitric oxide and beyond. Biochem. J. 1998;336:1&#x2013;17. doi: 10.1042/bj3360001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj3360001</ArticleId><ArticleId IdType="pmc">PMC1219836</ArticleId><ArticleId IdType="pubmed">9806879</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante W., Johnson F.K., Johnson R.A. Arginase: A critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 2007;34:906&#x2013;911. doi: 10.1111/j.1440-1681.2007.04638.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1681.2007.04638.x</ArticleId><ArticleId IdType="pmc">PMC1955221</ArticleId><ArticleId IdType="pubmed">17645639</ArticleId></ArticleIdList></Reference><Reference><Citation>Durante W. Targeting Arginine in COVID-19-induced immunopathology and vasculopathy. Metabolites. 2022;12:240. doi: 10.3390/metabo12030240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12030240</ArticleId><ArticleId IdType="pmc">PMC8953281</ArticleId><ArticleId IdType="pubmed">35323682</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg J.O., Weitzberg E. Nitric oxide signaling in health and disease. Cell. 2022;185:2853&#x2013;2878. doi: 10.1016/j.cell.2022.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.010</ArticleId><ArticleId IdType="pubmed">35931019</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Hein T.W., Wang W., Miller M.W., Fossum T.W., McDonald M.M., Humphrey J.D., Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44:935&#x2013;943. doi: 10.1161/01.HYP.0000146907.82869.f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.0000146907.82869.f2</ArticleId><ArticleId IdType="pubmed">15492130</ArticleId></ArticleIdList></Reference><Reference><Citation>Pernow J., Jung C. The Emerging role of arginase in endothelial dysfunction in diabetes. Curr. Vasc. Pharmacol. 2016;14:155&#x2013;162. doi: 10.2174/1570161114666151202205617.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570161114666151202205617</ArticleId><ArticleId IdType="pubmed">26638796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouzaut A., Subir&#xe1; M.L., De Miguel C., Domingo-De-Miguel E., Gonz&#xe1;lez A., Santiago E., L&#xf3;pez-Moratalla N. Co-expression of inducible nitric oxide synthase and arginases in different human monocyte subsets. Apoptosis regulated by endogenous NO. Biochim. Biophys. Acta. 1999;1451:319&#x2013;333. doi: 10.1016/S0167-4889(99)00106-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0167-4889(99)00106-8</ArticleId><ArticleId IdType="pubmed">10556586</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanc R.S., Richard S. Arginine methylation: The coming of age. Mol. Cell. 2017;65:8&#x2013;24. doi: 10.1016/j.molcel.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.11.003</ArticleId><ArticleId IdType="pubmed">28061334</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsikas D., Bollenbach A., Hanff E., Kayacelebi A.A. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): The ADMA, SDMA and hArg paradoxes. Cardiovasc. Diabetol. 2018;17:1. doi: 10.1186/s12933-017-0656-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0656-x</ArticleId><ArticleId IdType="pmc">PMC5753492</ArticleId><ArticleId IdType="pubmed">29301528</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger S., Sonntag S.R., Lieb W., Maas R. Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: A systematic review and meta-analysis of prospective studies. PLoS ONE. 2016;11:e0165811. doi: 10.1371/journal.pone.0165811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0165811</ArticleId><ArticleId IdType="pmc">PMC5094762</ArticleId><ArticleId IdType="pubmed">27812151</ArticleId></ArticleIdList></Reference><Reference><Citation>Willeit P., Freitag D.F., Laukkanen J.A., Chowdhury S., Gobin R., Mayr M., Di Angelantonio E., Chowdhury R. Asymmetric dimethylarginine and cardiovascular risk: Systematic review and meta-analysis of 22 prospective studies. J. Am. Heart Assoc. 2015;4:e001833. doi: 10.1161/JAHA.115.001833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.001833</ArticleId><ArticleId IdType="pmc">PMC4599532</ArticleId><ArticleId IdType="pubmed">26021436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Zhu Q., Li X., Chen C., Liu J., Ye Y., Ruan Y., Hei Z. Asymmetric dimethylarginine and all-cause mortality: A systematic review and meta-analysis. Sci. Rep. 2017;7:44692. doi: 10.1038/srep44692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44692</ArticleId><ArticleId IdType="pmc">PMC5353714</ArticleId><ArticleId IdType="pubmed">28294182</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo A., Varzideh F., Wilson S., Gambardella J., Eacobacci M., Jankauskas S.S., Donkor K., Kansakar U., Trimarco V., Mone P., et al. l-arginine and COVID-19: An update. Nutrients. 2021;13:3951. doi: 10.3390/nu13113951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13113951</ArticleId><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Calvani R., Picca A., Ciciarello F., Galluzzo V., Coelho-J&#xfa;nior H.J., Di Giorgio A., Di Mario C., Gervasoni J., Gremese E., et al. Effects of l-arginine plus vitamin c supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: A single-blind randomized controlled trial. Nutrients. 2022;14:4984. doi: 10.3390/nu14234984.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees C.A., Rostad C.A., Mantus G., Anderson E.J., Chahroudi A., Jaggi P., Wrammert J., Ochoa J.B., Ochoa A., Basu R.K., et al. Altered amino acid profile in patients with SARS-CoV-2 infection. Proc. Natl. Acad. Sci. USA. 2021;118:e2101708118. doi: 10.1073/pnas.2101708118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2101708118</ArticleId><ArticleId IdType="pmc">PMC8237604</ArticleId><ArticleId IdType="pubmed">34088793</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi A., Grassi G., Notari S., Gili S., Bordoni V., Tartaglia E., Casetti R., Cimini E., Mariotti D., Garotto G., et al. Expansion of myeloid derived suppressor cells contributes to platelet activation by L-arginine deprivation during SARS-CoV-2 infection. Cells. 2021;10:2111. doi: 10.3390/cells10082111.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082111</ArticleId><ArticleId IdType="pmc">PMC8391818</ArticleId><ArticleId IdType="pubmed">34440879</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F., Lesouhaitier M., Gregoire M., Pinceaux K., Gacouin A., Maamar A., Painvin B., Camus C., Le Tulzo Y., Tattevin P., et al. SARS-CoV-2-induced ARDS associates with MDSC expansion, lymphocyte dysfunction, and arginine shortage. J. Clin. Immunol. 2021;41:515&#x2013;525. doi: 10.1007/s10875-020-00920-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-020-00920-5</ArticleId><ArticleId IdType="pmc">PMC7775842</ArticleId><ArticleId IdType="pubmed">33387156</ArticleId></ArticleIdList></Reference><Reference><Citation>Karu N., Kindt A., van Gammeren A.J., Ermens A.A.M., Harms A.C., Portengen L., Vermeulen R.C.H., Dik W.A., Langerak A.W., van der Velden V.H.J., et al. Severe COVID-19 is characterised by perturbations in plasma amines correlated with immune response markers, and linked to inflammation and oxidative stress. Metabolites. 2022;12:618. doi: 10.3390/metabo12070618.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070618</ArticleId><ArticleId IdType="pmc">PMC9321395</ArticleId><ArticleId IdType="pubmed">35888742</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannemann J., Balfanz P., Schwedhelm E., Hartmann B., Ule J., M&#xfc;ller-Wieland D., Dahl E., Dreher M., Marx N., B&#xf6;ger R. Elevated serum SDMA and ADMA at hospital admission predict in-hospital mortality of COVID-19 patients. Sci. Rep. 2021;11:9895. doi: 10.1038/s41598-021-89180-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89180-w</ArticleId><ArticleId IdType="pmc">PMC8110746</ArticleId><ArticleId IdType="pubmed">33972591</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M., Ciciarello F., Zazzara M.B., Pais C., Savera G., Picca A., Galluzzo V., Coelho-J&#xfa;nior H.J., Calvani R., Marzetti E., et al. Nutraceuticals and dietary supplements for older adults with long COVID-19. Clin. Geriatr. Med. 2022;38:565&#x2013;591. doi: 10.1016/j.cger.2022.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9212635</ArticleId><ArticleId IdType="pubmed">35868674</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G., Coppola A., Izzo R., Annunziata A., Bernardo M., Lombardi A., Trimarco V., Santulli G., Trimarco B. Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine. 2021;40:101125. doi: 10.1016/j.eclinm.2021.101125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101125</ArticleId><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli M.B., Gambardella J., Castellanos V., Trimarco V., Santulli G. Vitamin C and cardiovascular disease: An update. Antioxidants. 2020;9:1227. doi: 10.3390/antiox9121227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9121227</ArticleId><ArticleId IdType="pmc">PMC7761826</ArticleId><ArticleId IdType="pubmed">33287462</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x110;uki&#x107; I., Kali&#x10d;anin N., Sencanski M., Pajovic S.B., Milicevic J., Prljic J., Paessler S., Prodanovi&#x107; R., Glisic S. Inhibition of SARS-CoV-2 Mpro with vitamin C, L-arginine and a aitamin C/L-arginine combination. Front. Biosci. Landmark Ed. 2023;28:8. doi: 10.31083/j.fbl2801008.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2801008</ArticleId><ArticleId IdType="pubmed">36722278</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo R., Trimarco V., Mone P., Alo&#xe8; T., Capra Marzani M., Diana A., Fazio G., Mallardo M., Maniscalco M., Marazzi G., et al. Combining L-arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey. Pharmacol. Res. 2022;183:106360. doi: 10.1016/j.phrs.2022.106360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2022.106360</ArticleId><ArticleId IdType="pmc">PMC9295384</ArticleId><ArticleId IdType="pubmed">35868478</ArticleId></ArticleIdList></Reference><Reference><Citation>A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. Oct 6, 2021.  [(accessed on 27 February 2023)].  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>ADMA&#x2014;Overview: Asymmetric Dimethylarginine, Plasma.  [(accessed on 27 February 2023)].  Available online:  https://www.mayocliniclabs.com/test-catalog/Overview/607697#Clinical-and-Interpretive.</Citation></Reference><Reference><Citation>ADMA/SDMA|Test Detail|Quest Diagnostics.  [(accessed on 27 February 2023)].  Available online:  https://testdirectory.questdiagnostics.com/test/test-detail/94153/admasdma?q=ADMA%2FSDMA&amp;cc=MASTER.</Citation></Reference><Reference><Citation>ADMA/SDMA.  [(accessed on 27 February 2023)].  Available online:  https://www.clevelandheartlab.com/wp-content/uploads/2018/11/CHL-D070-AUG2018-ADMA-SDMA-Practitioner-One-Pager.pdf.</Citation></Reference><Reference><Citation>Dean M.J., Ochoa J.B., Sanchez-Pino M.D., Zabaleta J., Garai J., Del Valle L., Wyczechowska D., Baiamonte L.B., Philbrook P., Majumder R., et al. Severe COVID-19 is characterized by an impaired type I interferon response and elevated levels of arginase producing granulocytic myeloid derived suppressor cells. Front. Immunol. 2021;12:695972. doi: 10.3389/fimmu.2021.695972.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.695972</ArticleId><ArticleId IdType="pmc">PMC8324422</ArticleId><ArticleId IdType="pubmed">34341659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Chen D., Ding W., Wu P., Hou H., Bai Y., Zhou Y., Li K., Xiang S., Liu P., et al. The trans-omics landscape of COVID-19. Nat. Commun. 2021;12:4543. doi: 10.1038/s41467-021-24482-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24482-1</ArticleId><ArticleId IdType="pmc">PMC8316550</ArticleId><ArticleId IdType="pubmed">34315889</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kuraishy H.M., Al-Gareeb A.I., Alexiou A., Batiha G.E.-S. COVID-19 and L-arginine supplementations: Yet to find the missed key. Curr. Protein Pept. Sci. 2022;23:166&#x2013;169. doi: 10.2174/1389203723666220512104039.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203723666220512104039</ArticleId><ArticleId IdType="pubmed">35549865</ArticleId></ArticleIdList></Reference><Reference><Citation>Canzano P., Brambilla M., Porro B., Cosentino N., Tortorici E., Vicini S., Poggio P., Cascella A., Pengo M.F., Veglia F., et al. Platelet and endothelial activation as potential mechanisms behind the thrombotic complications of COVID-19 patients. JACC Basic Transl. Sci. 2021;6:202&#x2013;218. doi: 10.1016/j.jacbts.2020.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2020.12.009</ArticleId><ArticleId IdType="pmc">PMC7904280</ArticleId><ArticleId IdType="pubmed">33649738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W.H.W., Wang Z., Cho L., Brennan D.M., Hazen S.L. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J. Am. Coll. Cardiol. 2009;53:2061&#x2013;2067. doi: 10.1016/j.jacc.2009.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.036</ArticleId><ArticleId IdType="pmc">PMC2755213</ArticleId><ArticleId IdType="pubmed">19477356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sourij H., Meinitzer A., Pilz S., Grammer T.B., Winkelmann B.R., Boehm B.O., M&#xe4;rz W. Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography. Atherosclerosis. 2011;218:220&#x2013;225. doi: 10.1016/j.atherosclerosis.2011.04.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2011.04.041</ArticleId><ArticleId IdType="pubmed">21632053</ArticleId></ArticleIdList></Reference><Reference><Citation>Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R.H., Bode-Boeger S.M., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J.S., Froelich J.C. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 1999;33:652&#x2013;658. doi: 10.1097/00005344-199904000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005344-199904000-00020</ArticleId><ArticleId IdType="pubmed">10218738</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervasoni J., Bonelli F., Zuppi C., Zappacosta B., Mordente A., Calvani R., Persichilli S. Determination of asymmetric dimethyl arginine in human serum by liquid chromatography-tandem mass spectrometry: Clinical application in hypertensive subjects. Clin. Chem. Lab. Med. 2011;49:2109&#x2013;2115. doi: 10.1515/CCLM.2011.691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2011.691</ArticleId><ArticleId IdType="pubmed">21892910</ArticleId></ArticleIdList></Reference><Reference><Citation>Krzyzanowska K., Mittermayer F., Wolzt M., Schernthaner G. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care. 2007;30:1834&#x2013;1839. doi: 10.2337/dc07-0019.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc07-0019</ArticleId><ArticleId IdType="pubmed">17456842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirinos J.A., David R., Bralley J.A., Zea-D&#xed;az H., Mu&#xf1;oz-Atahualpa E., Corrales-Medina F., Cuba-Bustinza C., Chirinos-Pacheco J., Medina-Lezama J. Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: The PREVENCION Study. Hypertension. 2008;52:1051&#x2013;1059. doi: 10.1161/HYPERTENSIONAHA.108.120352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.108.120352</ArticleId><ArticleId IdType="pubmed">18852383</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas R., Xanthakis V., Polak J.F., Schwedhelm E., Sullivan L.M., Benndorf R., Schulze F., Vasan R.S., Wolf P.A., B&#xf6;ger R.H., et al. Association of the endogenous nitric oxide synthase inhibitor ADMA with carotid artery intimal media thickness in the Framingham Heart Study offspring cohort. Stroke. 2009;40:2715&#x2013;2719. doi: 10.1161/STROKEAHA.109.552539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.109.552539</ArticleId><ArticleId IdType="pmc">PMC2749947</ArticleId><ArticleId IdType="pubmed">19498184</ArticleId></ArticleIdList></Reference><Reference><Citation>Janes F., Cif&#xf9; A., Pessa M.E., Domenis R., Gigli G.L., Sanvilli N., Nilo A., Garbo R., Curcio F., Giacomello R., et al. ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. Sci. Rep. 2019;9:14207. doi: 10.1038/s41598-019-50778-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-50778-w</ArticleId><ArticleId IdType="pmc">PMC6775279</ArticleId><ArticleId IdType="pubmed">31578412</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosse G.M., Schwedhelm E., Worthmann H., Choe C.U. Arginine derivatives in cerebrovascular diseases: Mechanisms and clinical implications. Int. J. Mol. Sci. 2020;21:1798. doi: 10.3390/ijms21051798.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051798</ArticleId><ArticleId IdType="pmc">PMC7084464</ArticleId><ArticleId IdType="pubmed">32150996</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavusoglu E., Ruwende C., Chopra V., Yanamadala S., Eng C., Pinsky D.J., Marmur J.D. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography. Coron. Artery Dis. 2009;20:112&#x2013;117. doi: 10.1097/MCA.0b013e328323982f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCA.0b013e328323982f</ArticleId><ArticleId IdType="pubmed">19240644</ArticleId></ArticleIdList></Reference><Reference><Citation>Valkonen V.P., P&#xe4;iv&#xe4; H., Salonen J.T., Lakka T.A., Lehtim&#xe4;ki T., Laakso J., Laaksonen R. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358:2127&#x2013;2128. doi: 10.1016/S0140-6736(01)07184-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(01)07184-7</ArticleId><ArticleId IdType="pubmed">11784629</ArticleId></ArticleIdList></Reference><Reference><Citation>Krempl T.K., Maas R., Sydow K., Meinertz T., B&#xf6;ger R.H., K&#xe4;hler J. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events. Eur. Heart J. 2005;26:1846&#x2013;1851. doi: 10.1093/eurheartj/ehi287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi287</ArticleId><ArticleId IdType="pubmed">15860520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavusoglu E., Ruwende C., Chopra V., Poludasu S., Yanamadala S., Frishman W.H., Eng C., Pinsky D.J., Marmur J.D. Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis. 2010;210:226&#x2013;231. doi: 10.1016/j.atherosclerosis.2009.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2009.10.034</ArticleId><ArticleId IdType="pubmed">19944421</ArticleId></ArticleIdList></Reference><Reference><Citation>Notsu Y., Yano S., Shibata H., Nagai A., Nabika T. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study. Atherosclerosis. 2015;239:61&#x2013;66. doi: 10.1016/j.atherosclerosis.2014.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2014.12.030</ArticleId><ArticleId IdType="pubmed">25576847</ArticleId></ArticleIdList></Reference><Reference><Citation>Notsu Y., Nabika T., Bokura H., Suyama Y., Kobayashi S., Yamaguchi S., Masuda J. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage. Am. J. Hypertens. 2009;22:257&#x2013;262. doi: 10.1038/ajh.2008.346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2008.346</ArticleId><ArticleId IdType="pubmed">19057516</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ger R.H., Endres H.G., Schwedhelm E., Darius H., Atzler D., L&#xfc;neburg N., von Stritzky B., Maas R., Thiem U., Benndorf R.A., et al. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. J. Intern. Med. 2010;269:349&#x2013;361. doi: 10.1111/j.1365-2796.2010.02322.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2010.02322.x</ArticleId><ArticleId IdType="pubmed">21175900</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: Hypothesized mechanisms and potential therapeutic approaches. J. Clin. Investig. 2022;132:e161167. doi: 10.1172/JCI161167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Wang C.Y., Wang S.I., Wei J.C.C. Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: A retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine. 2022;53:101619. doi: 10.1016/j.eclinm.2022.101619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101619</ArticleId><ArticleId IdType="pmc">PMC9366236</ArticleId><ArticleId IdType="pubmed">35971425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med. 2022;28:583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Strobel J., M&#xfc;ller F., Zolk O., Endre&#xdf; B., K&#xf6;nig J., Fromm M.F., Maas R. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1) Amino Acids. 2013;45:989&#x2013;1002. doi: 10.1007/s00726-013-1556-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-013-1556-3</ArticleId><ArticleId IdType="pubmed">23864433</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallance P., Leone A., Calver A., Collier J., Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 1992;20:S60&#x2013;S62. doi: 10.1097/00005344-199204002-00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005344-199204002-00018</ArticleId><ArticleId IdType="pubmed">1282988</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C.P., Zhao J.F., Lin S.J., Shyue S.K., Guo B.C., Lu T.M., Lee T.S. Asymmetric dimethylarginine limits the efficacy of simvastatin activating endothelial nitric oxide synthase. J. Am. Heart Assoc. 2016;5:e003327. doi: 10.1161/JAHA.116.003327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.116.003327</ArticleId><ArticleId IdType="pmc">PMC4843600</ArticleId><ArticleId IdType="pubmed">27091343</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode-B&#xf6;ger S.M., Scalera F., Ignarro L.J. The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol. Ther. 2007;114:295&#x2013;306. doi: 10.1016/j.pharmthera.2007.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2007.03.002</ArticleId><ArticleId IdType="pubmed">17482266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Sun L., Yang T., Sun K., Chen J., Hui R. Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2009;89:77&#x2013;84. doi: 10.3945/ajcn.2008.26544.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.2008.26544</ArticleId><ArticleId IdType="pubmed">19056561</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ger G.I., Rudolph T.K., Maas R., Schwedhelm E., Dumbadze E., Bierend A., Benndorf R.A., B&#xf6;ger R.H. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine. J. Am. Coll. Cardiol. 2007;49:2274&#x2013;2282. doi: 10.1016/j.jacc.2007.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.02.051</ArticleId><ArticleId IdType="pubmed">17560293</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker H.A., McGing E., Fisher I., B&#xf6;ger R.H., Bode-B&#xf6;ger S.M., Jackson G., Ritter J.M., Chowienczyk P.J. Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: Lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J. Am. Coll. Cardiol. 2001;38:499&#x2013;505. doi: 10.1016/S0735-1097(01)01380-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01380-8</ArticleId><ArticleId IdType="pubmed">11499744</ArticleId></ArticleIdList></Reference><Reference><Citation>Speakman L.L., Michienzi S.M., Badowski M.E. Vitamins, supplements and COVID-19: A review of currently available evidence. Drugs Context. 2021;10:2021-6-2. doi: 10.7573/dic.2021-6-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.7573/dic.2021-6-2</ArticleId><ArticleId IdType="pmc">PMC8496749</ArticleId><ArticleId IdType="pubmed">34659426</ArticleId></ArticleIdList></Reference><Reference><Citation>Veljkovi&#x107; M., Pavlovi&#x107; D.R., Stojanovi&#x107; N.M., D&#x17e;opali&#x107; T., Popovi&#x107; Dragonji&#x107; L. Behavioral and dietary habits that could influence both COVID-19 and non-communicable civilization disease prevention-what have we learned up to now? Medicina. 2022;58:1686. doi: 10.3390/medicina58111686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58111686</ArticleId><ArticleId IdType="pmc">PMC9695647</ArticleId><ArticleId IdType="pubmed">36422225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Meza C.A., Clarke H., Kim J.S., Hickner R.C. Vitamin D and endothelial function. Nutrients. 2020;12:575. doi: 10.3390/nu12020575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12020575</ArticleId><ArticleId IdType="pmc">PMC7071424</ArticleId><ArticleId IdType="pubmed">32098418</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo V., Ciciarello F., Tosato M., Zazzara M.B., Pais C., Savera G., Calvani R., Picca A., Marzetti E., Landi F. Association between vitamin D status and physical performance in COVID-19 survivors: Results from the Gemelli against COVID-19 Post-Acute Care project. Mech. Ageing Dev. 2022;205:111684. doi: 10.1016/j.mad.2022.111684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111684</ArticleId><ArticleId IdType="pmc">PMC9093083</ArticleId><ArticleId IdType="pubmed">35568146</ArticleId></ArticleIdList></Reference><Reference><Citation>Molinari C., Morsanuto V., Polli S., Uberti F. Cooperative effects of Q10, vitamin D3, and L-arginine on cardiac and endothelial cells. J. Vasc. Res. 2018;55:47&#x2013;60. doi: 10.1159/000484928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484928</ArticleId><ArticleId IdType="pubmed">29301117</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi F., Gremese E., Bernabei R., Fantoni M., Gasbarrini A., Settanni C.R., Benvenuto F., Bramato G., Carf&#xec; A., Ciciarello F., et al. Post-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin. Exp. Res. 2020;32:1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Indicazioni ad Interim sui Principi di Gestione del Long-COVID, Versione del 1&#xb0; Luglio 2021.  [(accessed on 24 February 2023)].  Available online:  https://www.iss.it/documents/20126/0/Rapporto+ISS+COVID-19+15_2021.pdf/a97f5be0-983b-efaa-2638-3cafc8380296?t=1625124332301.</Citation></Reference><Reference><Citation>Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977;1:385&#x2013;401. doi: 10.1177/014662167700100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/014662167700100306</ArticleId></ArticleIdList></Reference><Reference><Citation>Santucci L., Lomuscio S., Canu F., Primiano A., Persichilli S., Urbani A., Gervasoni J. A rapid method for determination of underivatized arginine-related metabolites in human plasma using LC&#x2212;MS/MS; Proceedings of the 54&#xb0; National Conference of Societ&#xe0; Italiana di Biochimica Clinica e Biologia Molecolare Clinica (SIBioC); Genoa, Italy. 5&#x2013;7 October 2022;  [(accessed on 18 November 2022)].  Available online:  https://bc.sibioc.it/bc/numero/bcnum/206.</Citation></Reference><Reference><Citation>St&#xe5;hle L., Wold S. Partial least squares analysis with cross-validation for the two-class problem: A Monte Carlo study. J. Chemom. 1987;1:185&#x2013;196. doi: 10.1002/cem.1180010306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cem.1180010306</ArticleId></ArticleIdList></Reference><Reference><Citation>Szyma&#x144;ska E., Saccenti E., Smilde A.K., Westerhuis J.A. Double-check: Validation of diagnostic statistics for PLS-DA models in metabolomics studies. Metabolomics. 2012;8:3&#x2013;16. doi: 10.1007/s11306-011-0330-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-011-0330-3</ArticleId><ArticleId IdType="pmc">PMC3337399</ArticleId><ArticleId IdType="pubmed">22593721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>